CluePoints Secures Coveted 2025 Scrip Award for Excellence in Clinical Trial Solutions

CluePoints Wins Prestigious Award

In a prominent ceremony held on December 11, 2025, at the London Hilton on Park Lane, CluePoints was awarded the title of 'Best Contract Research Organization – Specialist Providers' at the 2025 Scrip Awards. This recognition highlights the company's commitment to innovating the clinical trial landscape through advanced statistical methods and artificial intelligence (AI).

CluePoints is a leader in Risk-Based Quality Management (RBQM) and provides top-tier data quality oversight software tailored for clinical trials. Its cutting-edge developments were essential in helping the industry evolve how clinical trials are conducted, significantly enhancing data quality and regulatory compliance.

Recently, CluePoints introduced substantial enhancements to its multi-product software-as-a-service platform. Among the notable updates is the integration of the Time Similarity Test (TST) into the Central Monitoring Platform (CMP) and the launch of its Medical Safety Review (MSR) software.

The TST feature enables clinical trial sponsors to detect data anomalies quicker and more efficiently. By analyzing the timestamps of patient-reported outcomes (ePRO) data, TST identifies patterns where patients at a site submit data at suspiciously similar times—a potential indicator of data fabrication or non-compliance. This capability is designed to shorten timelines and reduce costs while ensuring higher data integrity.

The recently launched MSR software is set to revolutionize the medical review of clinical trial data. With user-friendly dashboards and a transparent data management process, it streamlines medical analysis, facilitating better communication around patient safety and enhancing oversight in clinical settings.

Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, expressed his pride in the team's achievement: "We are incredibly proud to have taken home yet another Scrip Award. This success is a testament to the hard work and dedication of the whole CluePoints team and the loyalty and innovative mindset of our customers, who use our software to accelerate the introduction of innovative therapies that benefit patients around the world."

For additional insights into CluePoints' award-winning technology solutions, visit CluePoints Website. The company's dedication to quality, innovation, and patient safety continues to set it apart in the competitive clinical research arena, as it aligns its operations with key regulatory guidance from FDA, EMA, and ICH E6 (R3).

CluePoints remains at the forefront of the industry’s paradigm shift towards RBQM, contributing to improved operational efficiency and reduced regulatory risks. This award not only recognizes CluePoints’ achievements but also reinforces its role in shaping the future of clinical research and development.